APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Blood Plasma Products and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Blood Plasma Products and Derivatives Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchAnimal Blood Plasma Products and Derivatives Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Blood Plasma Products and Derivatives Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Animal Blood Plasma Products and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Blood Plasma Products and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Blood Plasma Products and Derivatives Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal Blood Plasma Products and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Blood Plasma Products and Derivatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Blood Plasma Products and Derivatives market include Thermo Fisher Scientific, Sigma-Aldrich, Rocky Mountain Biologicals, Proliant, LAMPIRE Biological Laboratories, Lake Immunogenics, Kraeber & Co. GmbH, Bovogen Biologicals and Auckland BioSciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Blood Plasma Products and Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Blood Plasma Products and Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Blood Plasma Products and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Blood Plasma Products and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Blood Plasma Products and Derivatives Segment by Company

Thermo Fisher Scientific

Sigma-Aldrich

Rocky Mountain Biologicals

Proliant

LAMPIRE Biological Laboratories

Lake Immunogenics

Kraeber & Co. GmbH

Bovogen Biologicals

Auckland BioSciences

ANZCO Foods

Animal Blood Plasma Products and Derivatives Segment by Type

Serum Albumin

Fibrinogen

Fetal Bovine Serum

Immunoglobulin

Animal Blood Plasma Products and Derivatives Segment by Application

Pharmaceutical Industry

Diagnostic Industry

Sports Nutrition

Nutrition Supplements

Cell Culture Media

Food Industry

Cosmetic Industry

Pet Food Industry

Animal Blood Plasma Products and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal Blood Plasma Products and Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal Blood Plasma Products and Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Blood Plasma Products and Derivatives significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Blood Plasma Products and Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Blood Plasma Products and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Blood Plasma Products and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Blood Plasma Products and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Blood Plasma Products and Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Blood Plasma Products and Derivatives industry.

Chapter 3: Detailed analysis of Animal Blood Plasma Products and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal Blood Plasma Products and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal Blood Plasma Products and Derivatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Blood Plasma Products and Derivatives Industry Trends Table 2. Animal Blood Plasma Products and Derivatives Industry Drivers Table 3. Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges Table 4. Animal Blood Plasma Products and Derivatives Industry Restraints Table 5. Global Animal Blood Plasma Products and Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Blood Plasma Products and Derivatives Revenue Share by Company (2021-2026) Table 7. Global Animal Blood Plasma Products and Derivatives Sales Volume by Company (tons) & (2021-2026) Table 8. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Company (2021-2026) Table 9. Global Animal Blood Plasma Products and Derivatives Average Price (US$/kg) of Company (2021-2026) Table 10. Global Animal Blood Plasma Products and Derivatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal Blood Plasma Products and Derivatives Key Company Manufacturing Base & Headquarters Table 12. Global Animal Blood Plasma Products and Derivatives Company, Product Type & Application Table 13. Global Animal Blood Plasma Products and Derivatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Blood Plasma Products and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Serum Albumin Table 18. Significant Companies of Fibrinogen Table 19. Significant Companies of Fetal Bovine Serum Table 20. Significant Companies of Immunoglobulin Table 21. Global Animal Blood Plasma Products and Derivatives Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Animal Blood Plasma Products and Derivatives Sales Volume by Type (2021-2026) & (tons) Table 23. Global Animal Blood Plasma Products and Derivatives Sales Volume by Type (2027-2032) & (tons) Table 24. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Type (2021-2026) Table 25. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Type (2027-2032) Table 26. Global Animal Blood Plasma Products and Derivatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Animal Blood Plasma Products and Derivatives Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Animal Blood Plasma Products and Derivatives Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Type (2021-2026) Table 30. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceutical Industry Table 32. Significant Companies of Diagnostic Industry Table 33. Significant Companies of Sports Nutrition Table 34. Significant Companies of Nutrition Supplements Table 35. Significant Companies of Cell Culture Media Table 36. Significant Companies of Food Industry Table 37. Significant Companies of Cosmetic Industry Table 38. Significant Companies of Pet Food Industry Table 39. Global Animal Blood Plasma Products and Derivatives Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 40. Global Animal Blood Plasma Products and Derivatives Sales Volume by Application (2021-2026) & (tons) Table 41. Global Animal Blood Plasma Products and Derivatives Sales Volume by Application (2027-2032) & (tons) Table 42. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Application (2021-2026) Table 43. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Application (2027-2032) Table 44. Global Animal Blood Plasma Products and Derivatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Animal Blood Plasma Products and Derivatives Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Animal Blood Plasma Products and Derivatives Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Application (2021-2026) Table 48. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Application (2027-2032) Table 49. Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 50. Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2026) & (tons) Table 51. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2021-2026) Table 52. Global Animal Blood Plasma Products and Derivatives Sales by Region (2027-2032) & (tons) Table 53. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2027-2032) Table 54. Global Animal Blood Plasma Products and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Animal Blood Plasma Products and Derivatives Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Region (2021-2026) Table 57. Global Animal Blood Plasma Products and Derivatives Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Region (2027-2032) Table 59. Global Animal Blood Plasma Products and Derivatives Market Average Price (US$/kg) by Region (2021-2026) Table 60. Global Animal Blood Plasma Products and Derivatives Market Average Price (US$/kg) by Region (2027-2032) Table 61. Global Animal Blood Plasma Products and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 62. Global Animal Blood Plasma Products and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 64. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2021-2026) Table 65. Global Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 66. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2027-2032) Table 67. Global Animal Blood Plasma Products and Derivatives Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Animal Blood Plasma Products and Derivatives Sales Value Market Share by Country (2021-2026) Table 69. Global Animal Blood Plasma Products and Derivatives Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Animal Blood Plasma Products and Derivatives Sales Value Market Share by Country (2027-2032) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Sigma-Aldrich Company Information Table 77. Sigma-Aldrich Business Overview Table 78. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio Table 80. Sigma-Aldrich Recent Development Table 81. Rocky Mountain Biologicals Company Information Table 82. Rocky Mountain Biologicals Business Overview Table 83. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 85. Rocky Mountain Biologicals Recent Development Table 86. Proliant Company Information Table 87. Proliant Business Overview Table 88. Proliant Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Proliant Animal Blood Plasma Products and Derivatives Product Portfolio Table 90. Proliant Recent Development Table 91. LAMPIRE Biological Laboratories Company Information Table 92. LAMPIRE Biological Laboratories Business Overview Table 93. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio Table 95. LAMPIRE Biological Laboratories Recent Development Table 96. Lake Immunogenics Company Information Table 97. Lake Immunogenics Business Overview Table 98. Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio Table 100. Lake Immunogenics Recent Development Table 101. Kraeber & Co. GmbH Company Information Table 102. Kraeber & Co. GmbH Business Overview Table 103. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio Table 105. Kraeber & Co. GmbH Recent Development Table 106. Bovogen Biologicals Company Information Table 107. Bovogen Biologicals Business Overview Table 108. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 110. Bovogen Biologicals Recent Development Table 111. Auckland BioSciences Company Information Table 112. Auckland BioSciences Business Overview Table 113. Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio Table 115. Auckland BioSciences Recent Development Table 116. ANZCO Foods Company Information Table 117. ANZCO Foods Business Overview Table 118. ANZCO Foods Animal Blood Plasma Products and Derivatives Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio Table 120. ANZCO Foods Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Animal Blood Plasma Products and Derivatives Distributors List Table 124. Animal Blood Plasma Products and Derivatives Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Animal Blood Plasma Products and Derivatives Product Image Figure 2. Global Animal Blood Plasma Products and Derivatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal Blood Plasma Products and Derivatives Sales (2021-2032) & (tons) Figure 5. Global Animal Blood Plasma Products and Derivatives Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Animal Blood Plasma Products and Derivatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Serum Albumin Image Figure 10. Fibrinogen Image Figure 11. Fetal Bovine Serum Image Figure 12. Immunoglobulin Image Figure 13. Global Animal Blood Plasma Products and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Animal Blood Plasma Products and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Type (2021-2032) Figure 16. Global Animal Blood Plasma Products and Derivatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Animal Blood Plasma Products and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Type (2021-2032) Figure 19. Pharmaceutical Industry Image Figure 20. Diagnostic Industry Image Figure 21. Sports Nutrition Image Figure 22. Nutrition Supplements Image Figure 23. Cell Culture Media Image Figure 24. Food Industry Image Figure 25. Cosmetic Industry Image Figure 26. Pet Food Industry Image Figure 27. Global Animal Blood Plasma Products and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 28. Global Animal Blood Plasma Products and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Application (2021-2032) Figure 30. Global Animal Blood Plasma Products and Derivatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Animal Blood Plasma Products and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Application (2021-2032) Figure 33. Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 34. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Animal Blood Plasma Products and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Animal Blood Plasma Products and Derivatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 38. North America Animal Blood Plasma Products and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Animal Blood Plasma Products and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 44. South America Animal Blood Plasma Products and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Animal Blood Plasma Products and Derivatives Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Animal Blood Plasma Products and Derivatives Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Albumin
  • Fibrinogen
  • Fetal Bovine Serum
  • Immunoglobulin
Applications
  • Pharmaceutical Industry
  • Diagnostic Industry
  • Sports Nutrition
  • Nutrition Supplements
  • Cell Culture Media
  • Food Industry
  • Cosmetic Industry
  • Pet Food Industry
Companies covered
  • Thermo Fisher Scientific
  • Sigma-Aldrich
  • Rocky Mountain Biologicals
  • Proliant
  • LAMPIRE Biological Laboratories
  • Lake Immunogenics
  • Kraeber & Co. GmbH
  • Bovogen Biologicals
  • Auckland BioSciences
  • ANZCO Foods

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  4. 1.2.2 Global Animal Blood Plasma Products and Derivatives Sales Volume (2021-2032)
  5. 1.2.3 Global Animal Blood Plasma Products and Derivatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal Blood Plasma Products and Derivatives Market Dynamics
  1. 2.1 Animal Blood Plasma Products and Derivatives Industry Trends
  2. 2.2 Animal Blood Plasma Products and Derivatives Industry Drivers
  3. 2.3 Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges
  4. 2.4 Animal Blood Plasma Products and Derivatives Industry Restraints
3 Animal Blood Plasma Products and Derivatives Market by Company
  1. 3.1 Global Animal Blood Plasma Products and Derivatives Company Revenue Ranking in 2025
  2. 3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Company (2021-2026)
  3. 3.3 Global Animal Blood Plasma Products and Derivatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal Blood Plasma Products and Derivatives Average Price by Company (2021-2026)
  5. 3.5 Global Animal Blood Plasma Products and Derivatives Company Ranking (2024-2026)
  6. 3.6 Global Animal Blood Plasma Products and Derivatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal Blood Plasma Products and Derivatives Company Product Type and Application
  8. 3.8 Global Animal Blood Plasma Products and Derivatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal Blood Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal Blood Plasma Products and Derivatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal Blood Plasma Products and Derivatives Market by Type
  1. 4.1 Animal Blood Plasma Products and Derivatives Type Introduction
  2. 4.1.1 Serum Albumin
  3. 4.1.2 Fibrinogen
  4. 4.1.3 Fetal Bovine Serum
  5. 4.1.4 Immunoglobulin
  6. 4.2 Global Animal Blood Plasma Products and Derivatives Sales Volume by Type
  7. 4.2.1 Global Animal Blood Plasma Products and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Animal Blood Plasma Products and Derivatives Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Animal Blood Plasma Products and Derivatives Sales Value by Type
  11. 4.3.1 Global Animal Blood Plasma Products and Derivatives Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Animal Blood Plasma Products and Derivatives Sales Value by Type (2021-2032)
  13. 4.3.3 Global Animal Blood Plasma Products and Derivatives Sales Value Share by Type (2021-2032)
5 Animal Blood Plasma Products and Derivatives Market by Application
  1. 5.1 Animal Blood Plasma Products and Derivatives Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Diagnostic Industry
  4. 5.1.3 Sports Nutrition
  5. 5.1.4 Nutrition Supplements
  6. 5.1.5 Cell Culture Media
  7. 5.1.6 Food Industry
  8. 5.1.7 Cosmetic Industry
  9. 5.1.8 Pet Food Industry
  10. 5.2 Global Animal Blood Plasma Products and Derivatives Sales Volume by Application
  11. 5.2.1 Global Animal Blood Plasma Products and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Animal Blood Plasma Products and Derivatives Sales Volume by Application (2021-2032)
  13. 5.2.3 Global Animal Blood Plasma Products and Derivatives Sales Volume Share by Application (2021-2032)
  14. 5.3 Global Animal Blood Plasma Products and Derivatives Sales Value by Application
  15. 5.3.1 Global Animal Blood Plasma Products and Derivatives Sales Value by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Animal Blood Plasma Products and Derivatives Sales Value by Application (2021-2032)
  17. 5.3.3 Global Animal Blood Plasma Products and Derivatives Sales Value Share by Application (2021-2032)
6 Animal Blood Plasma Products and Derivatives Regional Sales and Value Analysis
  1. 6.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021-2026
  4. 6.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Region (2027-2032)
  5. 6.3 Global Animal Blood Plasma Products and Derivatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal Blood Plasma Products and Derivatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal Blood Plasma Products and Derivatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal Blood Plasma Products and Derivatives Sales Value by Region (2027-2032)
  9. 6.5 Global Animal Blood Plasma Products and Derivatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  12. 6.6.2 North America Animal Blood Plasma Products and Derivatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  15. 6.7.2 Europe Animal Blood Plasma Products and Derivatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  21. 6.9.2 South America Animal Blood Plasma Products and Derivatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal Blood Plasma Products and Derivatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal Blood Plasma Products and Derivatives Sales Value Share by Country, 2025 VS 2032
7 Animal Blood Plasma Products and Derivatives Country-level Sales and Value Analysis
  1. 7.1 Global Animal Blood Plasma Products and Derivatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Blood Plasma Products and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
  4. 7.3.1 Global Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
  5. 7.3.2 Global Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032)
  6. 7.4 Global Animal Blood Plasma Products and Derivatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal Blood Plasma Products and Derivatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal Blood Plasma Products and Derivatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal Blood Plasma Products and Derivatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal Blood Plasma Products and Derivatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal Blood Plasma Products and Derivatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Sigma-Aldrich
  8. 8.2.1 Sigma-Aldrich Company Information
  9. 8.2.2 Sigma-Aldrich Business Overview
  10. 8.2.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
  12. 8.2.5 Sigma-Aldrich Recent Developments
  13. 8.3 Rocky Mountain Biologicals
  14. 8.3.1 Rocky Mountain Biologicals Company Information
  15. 8.3.2 Rocky Mountain Biologicals Business Overview
  16. 8.3.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  18. 8.3.5 Rocky Mountain Biologicals Recent Developments
  19. 8.4 Proliant
  20. 8.4.1 Proliant Company Information
  21. 8.4.2 Proliant Business Overview
  22. 8.4.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
  24. 8.4.5 Proliant Recent Developments
  25. 8.5 LAMPIRE Biological Laboratories
  26. 8.5.1 LAMPIRE Biological Laboratories Company Information
  27. 8.5.2 LAMPIRE Biological Laboratories Business Overview
  28. 8.5.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
  30. 8.5.5 LAMPIRE Biological Laboratories Recent Developments
  31. 8.6 Lake Immunogenics
  32. 8.6.1 Lake Immunogenics Company Information
  33. 8.6.2 Lake Immunogenics Business Overview
  34. 8.6.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
  36. 8.6.5 Lake Immunogenics Recent Developments
  37. 8.7 Kraeber & Co. GmbH
  38. 8.7.1 Kraeber & Co. GmbH Company Information
  39. 8.7.2 Kraeber & Co. GmbH Business Overview
  40. 8.7.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
  42. 8.7.5 Kraeber & Co. GmbH Recent Developments
  43. 8.8 Bovogen Biologicals
  44. 8.8.1 Bovogen Biologicals Company Information
  45. 8.8.2 Bovogen Biologicals Business Overview
  46. 8.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  48. 8.8.5 Bovogen Biologicals Recent Developments
  49. 8.9 Auckland BioSciences
  50. 8.9.1 Auckland BioSciences Company Information
  51. 8.9.2 Auckland BioSciences Business Overview
  52. 8.9.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
  54. 8.9.5 Auckland BioSciences Recent Developments
  55. 8.10 ANZCO Foods
  56. 8.10.1 ANZCO Foods Company Information
  57. 8.10.2 ANZCO Foods Business Overview
  58. 8.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
  60. 8.10.5 ANZCO Foods Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Blood Plasma Products and Derivatives Value Chain Analysis
  2. 9.1.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Blood Plasma Products and Derivatives Sales Mode & Process
  6. 9.2 Animal Blood Plasma Products and Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Blood Plasma Products and Derivatives Distributors
  9. 9.2.3 Animal Blood Plasma Products and Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst